Huahai and Oncobiologics Create Broad Biosimilars PartnershipCRANBURY, N.J. The four biosimilars are generic versions of Humira®, Rituxan®, Avastin®, and Herceptin®. These biologics are the most popular therapies in the world for their respective cancer and immune-disease indications, representing annual ... PR Newswire, 2 weeks ago |
20 images for herceptin | ||||
Pediatrician fighting cancer headlines Sisters United eventTwo things are crucial for Dr. Neysa Heyward as she faces down her aggressive HER-2 breast cancer: One is the drug Herceptin; the other is her family and friends. The 1969 South High School graduate will talk about the importance of the medical and ... Individual.com, 1 month ago
Skipping Chemo to Treat a Breast Cancer
Daily Rx, 1 month ago
Study Challenges Notion of Using Herceptin for HER2-positive Breast Cancer
Med India, 2 months ago
Breast cancer
MayoClinic.com, 1 day ago
|
biOasis's Update on the BT2111-Herceptin(R) ProgramI biOasis Technologies Inc. (TSX VENTURE:BTI) announced today an update on the advancement of its anti-cancer product candidate BT2111. BT2111 is a brain-penetrating conjugate of trastuzumab (Herceptin®) and our Transcend vector designed to treat ... PipelineReview, 1 month ago
More from: BioMedReports, Reuters...and 2 other sources
|
Human medicines European Public Assessment Report (EPAR): Herceptin, trastuzumab, Revision: 19, AuthorisedHerceptin is a powder that is made up into a solution for infusion (drip into a vein). It contains the active substance trastuzumab. Herceptin is used to treat the following types of cancer: early breast cancer (when the cancer has spread within the ... European Medicines Agency, 1 month ago
|
Lung Cancer Patients Who Carry Specific HER2 Mutations may Benefit from Certain Anti-HER2 TreatmentsNew study suggest that anti-HER2 treatments, like the widely used breast cancer agent trastuzumab (Herceptin), have anti-cancer effects in a small subset of patients with advanced non-small cell lung cancer (NSCLC) harboring specific HER2 protein mutations. Med India, 3 weeks ago
Retrospective Study Suggests that Patients with Lung Cancer who Carry Specific HER2 Mutations May ...
Advance for Administrators of the Laboratory, 2 weeks ago
Anti-HER2 Therapy May Obviate Need for Chemotherapy in Advanced Breast Cancer
Oncology Times, 2 weeks ago
Endometrial Cancer Treatment May Be Reshaped By Genomics
MediLexicon, 3 weeks ago
|
Don't confuse Kadcyla with Herceptin, FDA saysThe FDA is picky about drug names. It's been known to reject brand monikers because they're too similar to others already out there in the market, worried that harried physicians and pharmacists might accidentally give patients the wrong one. But ... FiercePharma, 2 weeks ago
FDA Warning: Nonproprietary Name for Breast Cancer Drug Could Cause Medication Errors
PT Community, 2 weeks ago
|
Bio-Matrix Scientific Group's Regen BioPharma Acquires Cancer Vaccine Technology With Initial Focus on Breast Cancer"The blockbuster potential of cancer immune therapies is illustrated by the $1.66 Billion sales of Herceptin(2), a monoclonal antibody used to treat breast cancer, in 2011," said David Koos, Chairman and CEO of Bio-Matrix Scientific Group Inc. and ... Stockhouse Canada, 2 weeks ago
Bio-Matrix Scientific Group Inc.'s Acquires Cancer Vaccine Technology With Initial Focus on Breast Cancer
BioSpace, 2 weeks ago
Bio-Matrix Scientific Group Inc. (BMSN.OB)'s Regen BioPharma Acquires Cancer Vaccine Technology With Initial Focus on Breast Cancer
BioSpace, 2 weeks ago
Bio-Matrix Scientific Groups Regen BioPharma Acquires. . .
Equities.com, 2 weeks ago
|
Avastin, Herceptin and Tamiflu power Roche to 6% sales growth in Q1Cancer and flu powered Roche to an impressive 13% increase in U.S. pharma sales for the first quarter--and 6% growth in overall sales. The effects of a nasty flu season may wear off quickly, but two newly launched breast cancer drugs should help to ... FiercePharma, 1 month ago
Tamiflu and cancer drugs lift Roche
Yahoo! UK and Ireland, 2 weeks ago
Cancer drugs and Tamiflu lift Roche Q1 sales 5%
Economic Times, 1 month ago
Roche Confirms FY13 Forecast On Higher Q1 Sales
RTTNews.com, 1 month ago
|
New DNA Blood Test Could Increase Access To Herceptinnews headlines printer friendly Main Category: Breast CancerArticle Date: 02 May 2013A new blood test for women with breast cancer could identify more women who will benefit from the targeted treatment Herceptin without the need for uncomfortable ... MediLexicon, 3 weeks ago
|
Targeting HER2 in Lung CancerNon small cell lung cancer responds to Herceptin and other HER2 targeted therapies (dailyRx News) You may have heard of HER2-positive breast cancer. You may not know that this gene can also play a role in lung cancer. And anti-HER2 medications may ... Daily Rx, 1 month ago
HER2-Positive NSCLC Yields to Targeted Agents
MedPage Today, 1 month ago
|